Overexpression of cyclin Y in non-small cell lung cancer is associated with cancer cell proliferation

被引：8

作者：

Yue WenTao ^{[1
]}

Zhao XiaoTing ^{[1
]}

Zhang LiNa ^{[1
]}

Liu ZhiDong ^{[2
]}

Ma Li ^{[1
]}

Jia WenYun ^{[1
]}

Qian Zhe ^{[1
]}

Zhang ChunYan ^{[1
]}

Wang Yue ^{[1
]}

Yang XueHui ^{[1
]}

Xu ShaoFa ^{[2
]}

机构：

[1] Capital Med Univ, Beijing Chest Hosp, Dept Cellular Biol, Beijing 101149, Peoples R China

[2] Capital Med Univ, Beijing Chest Hosp, Dept Thorac Surg, Beijing 101149, Peoples R China

来源：

SCIENCE CHINA-LIFE SCIENCES | 2010年 / 53卷 / 04期

关键词：

CCNY; NSCLC; lentivirus RNAi; H1299; EXPRESSION; A1;

D O I：

10.1007/s11427-010-0090-8

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Cyclin Y (CCNY) is a key cell cycle regulator that acts as a growth factor sensor to integrate extracellular signals with the cell cycle machinery. The expression status of CCNY in lung cancer and its clinical significance remain unknown. The data indicates that CCNY may be deregulated in non-small cell lung cancer, where it may act to promote cell proliferation. These studies suggest that CCNY may be a candidate biomarker of NSCLC and a possible therapeutic target for lung cancer treatment.

引用

页码：511 / 516

页数：6

共 50 条

[41] Hypomethylation of the Thymosin β10 Gene Is Not Associated with Its Overexpression in Non-Small Cell Lung Cancer
Lee, Su Man
Na, Yeon Kyung
Hong, Hae Sook
Jang, Eun Jeong
Yoon, Ghil Suk
Park, Jae Yong
Kim, Dong Sun
MOLECULES AND CELLS, 2011, 32 (04) : 343 - 348
[42] Overexpression of PHRF1 attenuates the proliferation and tumorigenicity of non-small cell lung cancer cells
Wang, Yadong
Wang, Haiyu
Pan, Teng
Li, Li
Li, Jiangmin
Yang, Haiyan
ONCOTARGET, 2016, 7 (39) : 64360 - 64370
[43] Overexpression of immunohistochemical RhoA associated with poor prognosis in operable non-small cell lung cancer
Lou, Ming
Gao, Zhao-Jia
Zhu, Tao
Mao, Xiao-Liang
Yuan, Kai
Tong, Ji-Chun
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (06): : 7577 - 7584
[44] Estrogen receptor overexpression in non-small cell lung cancer is associated with better survival in males
Skov, Birgit Guldhammer
Fischer, Barbara M.
Pappot, Helle
APMIS, 2008, 116 (03) : 225 - 225
[45] Overexpression of Sphk2 is associated with gefitinib resistance in non-small cell lung cancer
Liu, Wei
Ning, Jinfeng
Li, Chunhong
Hu, Jing
Meng, Qingwei
Lu, Hailing
Cai, Li
TUMOR BIOLOGY, 2016, 37 (05) : 6331 - 6336
[46] Overexpression of CD44 is associated with the occurrence and migration of non-small cell lung cancer
Li, Guanghu
Gao, Yufei
Cui, Yongsheng
Zhang, Tao
Cui, Rui
Jiang, Yang
Shi, Jingwei
MOLECULAR MEDICINE REPORTS, 2016, 14 (04) : 3159 - 3167
[47] Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer
Hu, Z
Lin, DM
Yuan, JS
Xiao, T
Zhang, HS
Sun, WY
Han, NJ
Ma, Y
Di, XB
Gao, MX
Ma, JF
Zhang, JH
Cheng, SJ
Gao, YN
CLINICAL CANCER RESEARCH, 2005, 11 (13) : 4646 - 4652
[48] Overexpression of OCT4 is associated with gefitinib resistance in non-small cell lung cancer
Li, Bin
Yao, Zhouhong
Wan, Yunyan
Lin, Dianjie
ONCOTARGET, 2016, 7 (47) : 77342 - 77347
[49] Kallikrein-related peptidase 6 overexpression promotes non-small cell lung cancer cell proliferation and is associated with poor patient outcome
Heuze-Vourch, N.
Planque, C.
Guyetant, S.
Coco, C.
Blechet, C.
Parent, C.
Brillet, B.
Reverdiau, P.
Jourdan, M. L.
Courty, Y.
EJC SUPPLEMENTS, 2008, 6 (09): : 69 - 69
[50] Periostin is a Negative Prognostic Factor and Promotes Cancer Cell Proliferation in Non-Small Cell Lung Cancer
Okazaki, T.
Tamai, K.
Shibuya, R.
Nakamura, M.
Mochizuki, M.
Yamaguchi, K.
Abe, J.
Takahashi, S.
Satoh, K.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S523 - S524

← 1 2 3 4 5 →